Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilma Barcellini

Showing results (31-40 of 251) with videos related to

Pageof 26
Sort By:
European Journal of Internal Medicine|December 12, 2018
Autoimmune hemolytic anemia, autoimmune neutropenia and aplastic anemia in the elderlyWilma Barcellini, Bruno Fattizzo, Agostino Cortelezzi
Blood|April 15, 2025
Breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria throughout clinical trials: from definition to clinical practiceBruno Fattizzo, Francesco Versino, Wilma Barcellini
Journal of Clinical Immunology|April 14, 2016
Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune ThrombocytopeniaMaria Carrabba, Wilma Barcellini, Giovanna Fabio
Frontiers in Immunology|May 11, 2023
The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?Sigbjørn Berentsen, Bruno Fattizzo, Wilma Barcellini
Expert Opinion on Biological Therapy|October 24, 2023
Antibody based therapeutics for autoimmune hemolytic anemiaFrancesca Cavallaro, Wilma Barcellini, Bruno Fattizzo
Expert Review of Hematology|April 11, 2020
Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic proceduresWilma Barcellini, Juri Giannotta, Bruno Fattizzo
Journal of Blood Medicine|September 10, 2019
Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectivesWilma Barcellini, Bruno Fattizzo, Anna Zaninoni
Frontiers in Immunology|February 13, 2024
Editorial: Practical recommendations and consensus for the management of immune mediated hematologic diseasesBruno Fattizzo, Sigbjorn Berentsen, Wilma Barcellini
European Journal of Haematology|June 12, 2023
Molecular pharmacology in complement-mediated hemolytic disordersMarta Bortolotti, Wilma Barcellini, Bruno Fattizzo
Blood Reviews|August 14, 2025
Targeting the neonatal Fc receptor (FcRn) in hematologic conditions with a focus on warm autoimmune hemolytic anemiaBruno Fattizzo, Leona E Ling, Wilma Barcellini
Pageof 26

Showing results (31-40 of 251) with videos related to

Sort By:
Pageof 26
European Journal of Internal Medicine|December 12, 2018
Autoimmune hemolytic anemia, autoimmune neutropenia and aplastic anemia in the elderlyWilma Barcellini, Bruno Fattizzo, Agostino Cortelezzi
Blood|April 15, 2025
Breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria throughout clinical trials: from definition to clinical practiceBruno Fattizzo, Francesco Versino, Wilma Barcellini
Journal of Clinical Immunology|April 14, 2016
Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune ThrombocytopeniaMaria Carrabba, Wilma Barcellini, Giovanna Fabio
Frontiers in Immunology|May 11, 2023
The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?Sigbjørn Berentsen, Bruno Fattizzo, Wilma Barcellini
Expert Opinion on Biological Therapy|October 24, 2023
Antibody based therapeutics for autoimmune hemolytic anemiaFrancesca Cavallaro, Wilma Barcellini, Bruno Fattizzo
Expert Review of Hematology|April 11, 2020
Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic proceduresWilma Barcellini, Juri Giannotta, Bruno Fattizzo
Journal of Blood Medicine|September 10, 2019
Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectivesWilma Barcellini, Bruno Fattizzo, Anna Zaninoni
Frontiers in Immunology|February 13, 2024
Editorial: Practical recommendations and consensus for the management of immune mediated hematologic diseasesBruno Fattizzo, Sigbjorn Berentsen, Wilma Barcellini
European Journal of Haematology|June 12, 2023
Molecular pharmacology in complement-mediated hemolytic disordersMarta Bortolotti, Wilma Barcellini, Bruno Fattizzo
Blood Reviews|August 14, 2025
Targeting the neonatal Fc receptor (FcRn) in hematologic conditions with a focus on warm autoimmune hemolytic anemiaBruno Fattizzo, Leona E Ling, Wilma Barcellini
Pageof 26